文
论文分享
演练场
杂货铺
论文推荐
字
编辑器下载
登录
注册
A phase III, randomized, placebo-controlled trial of adjuvant nivolumab plus ipilimumab in patients (pts) with localized renal cell carcinoma (RCC) who are at high risk of relapse after radical or partial nephrectomy (CheckMate 914).
复制论文ID
分享
摘要
作者
参考文献
暂无分享,去
创建一个
R. Motzer
|
P. Russo
|
A. Bex
|
M. McHenry
|
E. Berghorn
|
V. Grünwald
|
Y. Tomita
保存到论文桶